J
Josemir W. Sander
Researcher at UCL Institute of Neurology
Publications - 705
Citations - 44517
Josemir W. Sander is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Epilepsy & Population. The author has an hindex of 106, co-authored 680 publications receiving 39038 citations. Previous affiliations of Josemir W. Sander include University of Cincinnati & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Outcome of seizures in the general population after 25 years: a prospective follow-up, observational cohort study
Gail S. Bell,Aidan Neligan,Christina Giavasi,Mark R. Keezer,Jan Novy,Janet L. Peacock,Janet L. Peacock,Anthony L. Johnson,DM Goodridge,Simon Shorvon,Josemir W. Sander +10 more
TL;DR: People with epilepsy and with single seizures at presentation in the community generally have good prognosis for seizure control with prolonged follow-up, and the risk of premature mortality is significantly increased in both groups.
Journal ArticleDOI
Suicidal ideation in epilepsy and levetiracetam therapy.
Marco Mula,Josemir W. Sander +1 more
TL;DR: Psychopathological characteristics of suicidal ideation were consistent in all subjects and similar to some features that are described as typical of the so-called interictal dysphoric disorder of epilepsy.
Journal ArticleDOI
Allergic skin rash with lamotrigine and concomitant valproate therapy: Evidence for an increased risk
TL;DR: In this paper, the authors assessed whether the risk of cutaneous rash was increased in patients receiving concomitant valproate therapy in a population of 103 adult patients with intractable epilepsy, who had lamotrigine added to their treatment.
Journal ArticleDOI
The long term retention of levetiracetam in a large cohort of patients with epilepsy
Chantal Depondt,A W C Yuen,G.D. Bell,Tejal N. Mitchell,Matthias J. Koepp,John S. Duncan,Josemir W. Sander +6 more
TL;DR: Patients attending a tertiary referral centre for epilepsy and who received Lev in the first 2 years of its marketing were assessed to determine continuation rates of treatment with this drug, and the retention rate for Lev compares favourably with that of other new AEDs.
Journal ArticleDOI
Serum brain-derived neurotrophic factor levels in epilepsy.
TL;DR: To clarify the utility of serum brain‐derived neurotrophic factor (BDNF) as a biomarker for epilepsy diagnosis and severity, a large number of patients with epilepsy were diagnosed with at least some forms of epilepsy.